Massimiliano Giacalone1, Zirilli Agata2, Paolo Carmelo Cozzucoli3, Angela Alibrandi2. 1. Department of Economics and Statistics, University of Naples Federico II, 80126, Naples, Italy. massimiliano.giacalone@unina.it. 2. Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, 98100, Messina, Italy. 3. Department of Economics, Statistics and Finance, University of Calabria, 87036, Rende, Cosenza, Italy.
Abstract
BACKGROUND: Statistical methodology is a powerful tool in the health research; however, there is wide accord that statistical methodologies are not usually used properly. In particular when multiple comparisons are needed, it is necessary to check the rate of false positive results and the potential inflation of type I errors. In this case, permutation testing methods are useful to check the simultaneous significance level and identify the most significant factors. METHODS: In this paper an application of permutation tests, in the medical context of Inflammatory Bowel Diseases, is performed. The main goal is to assess the existence of significant differences between Crohn's Disease (CD) and Ulcerative Colitis (UC). The Sequentially Rejective Multiple Test (Bonferroni-Holm procedure) is used to find which of the partial tests are effectively significant and solve the problem of the multiplicity control. RESULTS: Applying Non-Parametric Combination (NPC) Test for partial and combined tests we conclude that Crohn's Disease patients and Ulcerative Colitis patients differ between them for most examined variables. UC patients compared with the CD patients, have a higher diagnosis age, not show smoking status, proportion of patients treated with immunosuppressants or with biological drugs is lower than the CD patients, even if the duration of such therapies is longer. CD patients have a higher rate of re-hospitalization. Diabetes is more present in the sub-population of UC patients. Analyzing the Charlson score we can highlight that UC patients have a more severe clinical situation than CD patients. Finally, CD patients are more frequently subject to surgery compared to UC. Appling of the Bonferroni Holm procedure, which provided adjusted p-values, we note that only nine of the examined variables are statistically significant: Smoking habit, Immunosuppressive therapy, Surgery, Biological Drug, Diabetes, Adverse Events, Re-hospitalization, Gender and Duration of Immunosoppressive Therapy. Therefore, we can conclude that these are the specific variables that can discriminate effectively the Crohn's Disease and Ulcerative Colitis groups. CONCLUSIONS: We identified significant variables that discriminate the two groups, satisfying the multiplicity problem, in fact we can affirm that Smoking habit, Immunosuppressive therapy, Surgery, Biological Drug, Diabetes, Adverse Events, Hospitalization, Gender and Duration of Immunosoppressive Therapy are the effectively significant variables.
BACKGROUND: Statistical methodology is a powerful tool in the health research; however, there is wide accord that statistical methodologies are not usually used properly. In particular when multiple comparisons are needed, it is necessary to check the rate of false positive results and the potential inflation of type I errors. In this case, permutation testing methods are useful to check the simultaneous significance level and identify the most significant factors. METHODS: In this paper an application of permutation tests, in the medical context of Inflammatory Bowel Diseases, is performed. The main goal is to assess the existence of significant differences between Crohn's Disease (CD) and Ulcerative Colitis (UC). The Sequentially Rejective Multiple Test (Bonferroni-Holm procedure) is used to find which of the partial tests are effectively significant and solve the problem of the multiplicity control. RESULTS: Applying Non-Parametric Combination (NPC) Test for partial and combined tests we conclude that Crohn's Diseasepatients and Ulcerative Colitispatients differ between them for most examined variables. UC patients compared with the CDpatients, have a higher diagnosis age, not show smoking status, proportion of patients treated with immunosuppressants or with biological drugs is lower than the CDpatients, even if the duration of such therapies is longer. CDpatients have a higher rate of re-hospitalization. Diabetes is more present in the sub-population of UC patients. Analyzing the Charlson score we can highlight that UC patients have a more severe clinical situation than CDpatients. Finally, CDpatients are more frequently subject to surgery compared to UC. Appling of the Bonferroni Holm procedure, which provided adjusted p-values, we note that only nine of the examined variables are statistically significant: Smoking habit, Immunosuppressive therapy, Surgery, Biological Drug, Diabetes, Adverse Events, Re-hospitalization, Gender and Duration of Immunosoppressive Therapy. Therefore, we can conclude that these are the specific variables that can discriminate effectively the Crohn's Disease and Ulcerative Colitis groups. CONCLUSIONS: We identified significant variables that discriminate the two groups, satisfying the multiplicity problem, in fact we can affirm that Smoking habit, Immunosuppressive therapy, Surgery, Biological Drug, Diabetes, Adverse Events, Hospitalization, Gender and Duration of Immunosoppressive Therapy are the effectively significant variables.
Authors: M Racioppi; L Salmaso; C Brombin; R Arboretti; D D'Agostino; R Colombo; V Serretta; M Brausi; G Casetta; P Gontero; R Hurle; R Tenaglia; V Altieri; R Bartoletti; M Maffezzini; S Siracusano; G Morgia; P F Bassi Journal: Urol Int Date: 2014-08-27 Impact factor: 2.089
Authors: T Ranzi; P Bodini; A Zambelli; P Politi; G Lupinacci; M C Campanini; A L Dal Lago; D Lisciandrano; P A Bianchi Journal: Eur J Gastroenterol Hepatol Date: 1996-07 Impact factor: 2.566
Authors: Elizabeth Paz-Pacheco; Jose B Nevado; Eva Maria C Cutiongco-de la Paz; Gabriel V Jasul; Aimee Yvonne Criselle L Aman; Elizabeth Laurize A Ribaya; Mark David G Francisco; Ma Luz Vicenta V Guanzon; May L Uyking-Naranjo; Ma Cecille S Añonuevo-Cruz; Maria Patricia Deanna D Maningat; Cristina V Jaring; Paulette D Nacpil-Dominguez; Aniza B Pala-Mohamad; Abigail U Canto; John Paul M Quisumbing; Annabelle Marie M Lat; Diane Carla C Bernardo; Noemie Marie M Mansibang; Karell Jo Angelique C Calpito; Vincent Sean D Ribaya; Julius Patrick Y Ferrer; Jessica H Biwang; Jodelyn B Melegrito; Christian Deo T Deguit; Carlos Emmanuel G Panerio Journal: J Endocr Soc Date: 2022-06-29
Authors: Njål Lura; Kari S Wagner-Larsen; David Forsse; Jone Trovik; Mari K Halle; Bjørn I Bertelsen; Øyvind Salvesen; Kathrine Woie; Camilla Krakstad; Ingfrid S Haldorsen Journal: Insights Imaging Date: 2022-06-17
Authors: Veerle R Smaardijk; Paul Lodder; Willem J Kop; Bente van Gennep; Angela H E M Maas; Paula M C Mommersteeg Journal: J Am Heart Assoc Date: 2019-05-07 Impact factor: 5.501
Authors: Stephanie G Harshman; Olivia Wons; Madeline S Rogers; Alyssa M Izquierdo; Tara M Holmes; Reitumetse L Pulumo; Elisa Asanza; Kamryn T Eddy; Madhusmita Misra; Nadia Micali; Elizabeth A Lawson; Jennifer J Thomas Journal: Nutrients Date: 2019-08-27 Impact factor: 5.717